Differentiation of glucose toxicity from beta cell exhaustion during the evolution of defective insulin gene expression in the pancreatic islet cell line, HIT-T15

A Moran, H J Zhang, L K Olson, J S Harmon, V Poitout, R P Robertson, A Moran, H J Zhang, L K Olson, J S Harmon, V Poitout, R P Robertson

Abstract

Chronic exposure of HIT-T15 cells to supraphysiologic glucose concentration diminishes insulin gene expression and decreased binding of two critical insulin gene transcription factors, STF-1 and RIPE-3b1 activator. To distinguish whether these changes are caused by glucose toxicity or beta cell exhaustion, HIT-T15 cells grown from passage 75 through 99 in media containing 11.1 mM glucose were switched to 0.8 mM glucose at passage 100. They regained binding of STF-1 and RIPE-3b1 activator and had a partial but minimal return of insulin mRNA expression. In a second study, inclusion of somatostatin in the media-containing 11.1 mM glucose inhibited insulin secretion; however, despite this protection against beta cell exhaustion, dramatic decreases in insulin gene expression, STF-1 and RIPE-3b1 binding, and insulin gene promoter activity still occurred. These data indicate that the glucotoxic effects caused by chronic exposure to supraphysiologic concentration of glucose are only minimally reversible and that they are not due simply to beta cell exhaustion. These observations carry with them the clinical implication that Type II diabetic patients who remain hyperglycemic for prolonged periods may have secondary glucose toxic effects on the beta cell that could lead to defective insulin gene expression and worsening of hyperglycemia.

References

    1. Diabetes. 1990 Dec;39(12):1580-3
    1. Anal Biochem. 1987 Apr;162(1):156-9
    1. Endocrinology. 1991 Oct;129(4):2067-76
    1. Endocrinology. 1991 Nov;129(5):2409-14
    1. J Clin Invest. 1992 Aug;90(2):320-5
    1. J Clin Invest. 1992 Oct;90(4):1263-8
    1. Endocr Rev. 1992 Aug;13(3):415-31
    1. J Clin Invest. 1993 Jul;92(1):514-9
    1. Diabetes. 1994 Feb;43(2):173-9
    1. Diabetes. 1994 Apr;43(4):546-51
    1. Diabetes. 1994 Sep;43(9):1085-9
    1. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9127-31
    1. Mol Endocrinol. 1995 Sep;9(9):1127-34
    1. J Clin Invest. 1996 Feb 15;97(4):1041-6
    1. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4339-43
    1. Metabolism. 1982 Feb;31(2):139-42
    1. Diabetes. 1987 Sep;36(9):1047-53
    1. Diabetes. 1988 May;37(5):600-9
    1. Diabetes. 1989 Jan;38(1):44-8
    1. Endocrinology. 1989 Oct;125(4):1999-2007
    1. Diabetes. 1989 Dec;38(12):1501-5
    1. Diabetes Care. 1990 Jun;13(6):610-30
    1. Diabetes. 1984 Mar;33(3):297-300
    1. Diabetologia. 1985 Mar;28(3):119-21
    1. Am J Physiol. 1986 May;250(5 Pt 1):E502-11
    1. FEBS Lett. 1987 Mar 9;213(1):149-54
    1. J Clin Endocrinol Metab. 1991 Jan;72(1):202-8

Source: PubMed

3
Subscribe